Brainstorm Cell Therapeutics Inc
NASDAQ:BCLI

Watchlist Manager
Brainstorm Cell Therapeutics Inc Logo
Brainstorm Cell Therapeutics Inc
NASDAQ:BCLI
Watchlist
Price: 1.36 USD 3.03% Market Closed
Market Cap: 8.9m USD
Have any thoughts about
Brainstorm Cell Therapeutics Inc?
Write Note

Intrinsic Value

BCLI's intrinsic value estimate is unreliable because it is based only on its DCF value and doesn't use a relative valuation using multiples.

The intrinsic value of one BCLI stock under the Base Case scenario is 0.03 USD. Compared to the current market price of 1.36 USD, Brainstorm Cell Therapeutics Inc is Overvalued by 98%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

BCLI Intrinsic Value
0.03 USD
Overvaluation 98%
Intrinsic Value
Price
Worst Case
Base Case
Best Case

Valuation History
Brainstorm Cell Therapeutics Inc

Intrinsic Value History
Dive into the past to invest in the future

Uncover deeper insights with the Valuation History. Learn how current stock valuations stack up against historical averages to gauge true investment potential.

Start now and learn if your stock is truly undervalued or overvalued!

Start Valuation
Backtest Conclusion
Very Attractive
Current Valuation
+45%
Avg Valuation
-12%
Worst Valuation
-49%
Best Valuation
+45%

Stock is trading at its lowest valuation over the past 5 years.

Backtest Example
BCLI
Valuation History
HIDDEN
Show
Valuation History Unavailable

Historical valuation for BCLI cannot be conducted due to limitations such as insufficient data or other constraints.

Valuation In Progress...
Valuation In Progress...

Fundamental Analysis

Brainstorm Cell Therapeutics Inc
NASDAQ:BCLI
US
Biotechnology
Market Cap
8.4m USD
IPO
May 28, 2003
US
Biotechnology
Market Cap
8.4m USD
IPO
May 28, 2003
Price
$
$
Company Overview
Loading...
Economic Moat
Loading...
Earnings Call
Loading...
Management
Loading...
Contacts
Loading...
AI Assistant
AI Assistant
Ask me anything about Brainstorm Cell Therapeutics Inc

Provide an overview of the primary business activities
of Brainstorm Cell Therapeutics Inc.

What unique competitive advantages
does Brainstorm Cell Therapeutics Inc hold over its rivals?

What risks and challenges
does Brainstorm Cell Therapeutics Inc face in the near future?

Has there been any significant insider trading activity
in Brainstorm Cell Therapeutics Inc recently?

Summarize the latest earnings call
of Brainstorm Cell Therapeutics Inc.

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for Brainstorm Cell Therapeutics Inc.

Provide P/S
for Brainstorm Cell Therapeutics Inc.

Provide P/E
for Brainstorm Cell Therapeutics Inc.

Provide P/OCF
for Brainstorm Cell Therapeutics Inc.

Provide P/FCFE
for Brainstorm Cell Therapeutics Inc.

Provide P/B
for Brainstorm Cell Therapeutics Inc.

Provide EV/S
for Brainstorm Cell Therapeutics Inc.

Provide EV/GP
for Brainstorm Cell Therapeutics Inc.

Provide EV/EBITDA
for Brainstorm Cell Therapeutics Inc.

Provide EV/EBIT
for Brainstorm Cell Therapeutics Inc.

Provide EV/OCF
for Brainstorm Cell Therapeutics Inc.

Provide EV/FCFF
for Brainstorm Cell Therapeutics Inc.

Provide EV/IC
for Brainstorm Cell Therapeutics Inc.

Show me price targets
for Brainstorm Cell Therapeutics Inc made by professional analysts.

What are the Revenue projections
for Brainstorm Cell Therapeutics Inc?

How accurate were the past Revenue estimates
for Brainstorm Cell Therapeutics Inc?

What are the Net Income projections
for Brainstorm Cell Therapeutics Inc?

How accurate were the past Net Income estimates
for Brainstorm Cell Therapeutics Inc?

What are the EPS projections
for Brainstorm Cell Therapeutics Inc?

How accurate were the past EPS estimates
for Brainstorm Cell Therapeutics Inc?

What are the EBIT projections
for Brainstorm Cell Therapeutics Inc?

How accurate were the past EBIT estimates
for Brainstorm Cell Therapeutics Inc?

Compare the revenue forecasts
for Brainstorm Cell Therapeutics Inc with those of its competitors based on recent analyst estimates.

Compare the intrinsic valuations
of Brainstorm Cell Therapeutics Inc and its key competitors using the latest financial data.

Compare historical revenue growth rates
of Brainstorm Cell Therapeutics Inc against its competitors.

Analyze the profit margins
(gross, operating, and net) of Brainstorm Cell Therapeutics Inc compared to its peers.

Compare the P/E ratios
of Brainstorm Cell Therapeutics Inc against its peers.

Discuss the investment returns and shareholder value creation
comparing Brainstorm Cell Therapeutics Inc with its peers.

Analyze the financial leverage
of Brainstorm Cell Therapeutics Inc compared to its main competitors.

Show all profitability ratios
for Brainstorm Cell Therapeutics Inc.

Provide ROE
for Brainstorm Cell Therapeutics Inc.

Provide ROA
for Brainstorm Cell Therapeutics Inc.

Provide ROIC
for Brainstorm Cell Therapeutics Inc.

Provide ROCE
for Brainstorm Cell Therapeutics Inc.

Provide Gross Margin
for Brainstorm Cell Therapeutics Inc.

Provide Operating Margin
for Brainstorm Cell Therapeutics Inc.

Provide Net Margin
for Brainstorm Cell Therapeutics Inc.

Provide FCF Margin
for Brainstorm Cell Therapeutics Inc.

Show all solvency ratios
for Brainstorm Cell Therapeutics Inc.

Provide D/E Ratio
for Brainstorm Cell Therapeutics Inc.

Provide D/A Ratio
for Brainstorm Cell Therapeutics Inc.

Provide Interest Coverage Ratio
for Brainstorm Cell Therapeutics Inc.

Provide Altman Z-Score Ratio
for Brainstorm Cell Therapeutics Inc.

Provide Quick Ratio
for Brainstorm Cell Therapeutics Inc.

Provide Current Ratio
for Brainstorm Cell Therapeutics Inc.

Provide Cash Ratio
for Brainstorm Cell Therapeutics Inc.

What is the historical Revenue growth
over the last 5 years for Brainstorm Cell Therapeutics Inc?

What is the historical Net Income growth
over the last 5 years for Brainstorm Cell Therapeutics Inc?

What is the current Free Cash Flow
of Brainstorm Cell Therapeutics Inc?

Discuss the annual earnings per share (EPS)
trend over the past five years for Brainstorm Cell Therapeutics Inc.

Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
Brainstorm Cell Therapeutics Inc

Current Assets 385k
Cash & Short-Term Investments 187k
Receivables 63k
Other Current Assets 135k
Non-Current Assets 1.4m
PP&E 1.2m
Other Non-Current Assets 206k
Current Liabilities 9m
Accounts Payable 6.1m
Accrued Liabilities 1.2m
Other Current Liabilities 1.7m
Non-Current Liabilities 618k
Other Non-Current Liabilities 618k
Efficiency

Free Cash Flow Analysis
Brainstorm Cell Therapeutics Inc

Last Value
3-Years Average
FCF Margin
Conversion Rate

Earnings Waterfall
Brainstorm Cell Therapeutics Inc

Revenue
0 USD
Operating Expenses
-11.7m USD
Operating Income
-11.7m USD
Other Expenses
70k USD
Net Income
-11.6m USD
Fundamental Scores

BCLI Profitability Score
Profitability Due Diligence

Brainstorm Cell Therapeutics Inc's profitability score is 71/100. The higher the profitability score, the more profitable the company is.

Exceptional 3-Year Average ROE
Exceptional 3-Year Average ROIC
Exceptional ROE
Exceptional ROIC
71/100
Profitability
Score

Brainstorm Cell Therapeutics Inc's profitability score is 71/100. The higher the profitability score, the more profitable the company is.

BCLI Solvency Score
Solvency Due Diligence

Brainstorm Cell Therapeutics Inc's solvency score is 34/100. The higher the solvency score, the more solvent the company is.

Low D/E
Long-Term Solvency
Short-Term Solvency
Low Altman Z-Score
34/100
Solvency
Score

Brainstorm Cell Therapeutics Inc's solvency score is 34/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

BCLI Price Targets Summary
Brainstorm Cell Therapeutics Inc

There are no price targets for BCLI.
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
View Analyst Estimates
View Analyst Estimates

Dividends

Brainstorm Cell Therapeutics Inc
does not pay dividends
Shareholder Yield

Current shareholder yield for BCLI is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
No dividends
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Ownership

BCLI Insider Trading
Buy and sell transactions by insiders

BCLI News

What is the Intrinsic Value of one BCLI stock?

The intrinsic value of one BCLI stock under the Base Case scenario is 0.03 USD.

Is BCLI stock undervalued or overvalued?

Compared to the current market price of 1.36 USD, Brainstorm Cell Therapeutics Inc is Overvalued by 98%.

Back to Top